Is KIDS or AXGN more profitable?

AxoGen has a net margin of -13.21% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat AxoGen's return on equity. Company Net Margins Return on Equity Return on Assets OrthoPediatrics -16.31% -7.01% -4.86% AxoGen -13.21% -9.63% -6.26%

Does the media refer more to KIDS or AXGN?

In the previous week, OrthoPediatrics and OrthoPediatrics both had 4 articles in the media. OrthoPediatrics' average media sentiment score of 1.06 beat AxoGen's score of 0.80 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BFLY or KIDS?

In the previous week, Butterfly Network had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 5 mentions for Butterfly Network and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.06 beat Butterfly Network's score of 0.34 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral OrthoPediatrics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor KIDS or NVCR?

In the previous week, NovoCure had 30 more articles in the media than OrthoPediatrics. MarketBeat recorded 34 mentions for NovoCure and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.06 beat NovoCure's score of 0.76 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NovoCure 10 Very Positive mention(s) 5 Positive mention(s) 3 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to KIDS or PLSE?

In the previous week, OrthoPediatrics and OrthoPediatrics both had 4 articles in the media. OrthoPediatrics' average media sentiment score of 1.06 beat Pulse Biosciences' score of 0.52 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulse Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer EYE or KIDS?

In the previous week, National Vision had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 6 mentions for National Vision and 4 mentions for OrthoPediatrics. National Vision's average media sentiment score of 1.58 beat OrthoPediatrics' score of 1.06 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive OrthoPediatrics 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

OrthoPediatrics (KIDS) Competitors

$18.87 +0.15 (+0.80%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$18.87 0.00 (0.00%)

As of 07/24/2026 04:10 PM Eastern

Compare

KIDS vs. AXGN, BFLY, NVCR, PLSE, and EYE

Should you buy OrthoPediatrics stock or one of its competitors? MarketBeat compares OrthoPediatrics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with OrthoPediatrics include AxoGen (AXGN), Butterfly Network (BFLY), NovoCure (NVCR), Pulse Biosciences (PLSE), and National Vision (EYE). These companies are all part of the "medical equipment" industry.

How does OrthoPediatrics compare to AxoGen?

OrthoPediatrics (NASDAQ:KIDS) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

OrthoPediatrics has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, AxoGen has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market.

In the previous week, OrthoPediatrics and OrthoPediatrics both had 4 articles in the media. OrthoPediatrics' average media sentiment score of 1.06 beat AxoGen's score of 0.80 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AxoGen	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OrthoPediatrics currently has a consensus target price of $24.78, indicating a potential upside of 31.31%. AxoGen has a consensus target price of $46.50, indicating a potential upside of 17.75%. Given OrthoPediatrics' higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by insiders. Comparatively, 2.4% of AxoGen shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

AxoGen has a net margin of -13.21% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
AxoGen	-13.21%	-9.63%	-6.26%

AxoGen has lower revenue, but higher earnings than OrthoPediatrics. AxoGen is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.05	-$39.65M	-$1.68	N/A
AxoGen	$225.21M	9.32	-$15.70M	-$0.64	N/A

Summary

OrthoPediatrics beats AxoGen on 7 of the 13 factors compared between the two stocks.

How does OrthoPediatrics compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, media sentiment, valuation, risk, analyst recommendations and dividends.

Butterfly Network presently has a consensus target price of $5.56, suggesting a potential downside of 14.20%. OrthoPediatrics has a consensus target price of $24.78, suggesting a potential upside of 31.31%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, analysts clearly believe OrthoPediatrics is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

Butterfly Network has a beta of 2.05, indicating that its share price is 105% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market.

In the previous week, Butterfly Network had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 5 mentions for Butterfly Network and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.06 beat Butterfly Network's score of 0.34 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
OrthoPediatrics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OrthoPediatrics has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$102.92M	16.04	-$77.06M	-$0.30	N/A
OrthoPediatrics	$236.35M	2.05	-$39.65M	-$1.68	N/A

37.8% of Butterfly Network shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 22.0% of Butterfly Network shares are held by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

OrthoPediatrics has a net margin of -16.31% compared to Butterfly Network's net margin of -73.63%. OrthoPediatrics' return on equity of -7.01% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-73.63%	-34.41%	-23.91%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

Summary

OrthoPediatrics beats Butterfly Network on 12 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to NovoCure?

OrthoPediatrics (NASDAQ:KIDS) and NovoCure (NASDAQ:NVCR) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

OrthoPediatrics has a net margin of -16.31% compared to NovoCure's net margin of -21.25%. OrthoPediatrics' return on equity of -7.01% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
NovoCure	-21.25%	-44.02%	-15.09%

In the previous week, NovoCure had 30 more articles in the media than OrthoPediatrics. MarketBeat recorded 34 mentions for NovoCure and 4 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.06 beat NovoCure's score of 0.76 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NovoCure	10 Very Positive mention(s)	5 Positive mention(s)	3 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 84.6% of NovoCure shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by company insiders. Comparatively, 5.5% of NovoCure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

OrthoPediatrics has higher earnings, but lower revenue than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.05	-$39.65M	-$1.68	N/A
NovoCure	$674.41M	3.03	-$136.23M	-$1.30	N/A

OrthoPediatrics presently has a consensus price target of $24.78, suggesting a potential upside of 31.31%. NovoCure has a consensus price target of $21.20, suggesting a potential upside of 20.11%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, equities analysts clearly believe OrthoPediatrics is more favorable than NovoCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
NovoCure	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

OrthoPediatrics has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, NovoCure has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market.

Summary

OrthoPediatrics beats NovoCure on 11 of the 16 factors compared between the two stocks.

How does OrthoPediatrics compare to Pulse Biosciences?

OrthoPediatrics (NASDAQ:KIDS) and Pulse Biosciences (NASDAQ:PLSE) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

OrthoPediatrics currently has a consensus target price of $24.78, suggesting a potential upside of 31.31%. Pulse Biosciences has a consensus target price of $30.67, suggesting a potential upside of 1.44%. Given OrthoPediatrics' stronger consensus rating and higher possible upside, equities analysts plainly believe OrthoPediatrics is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

OrthoPediatrics has a beta of 0.99, meaning that its share price is 1% less volatile than the broader market. Comparatively, Pulse Biosciences has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market.

OrthoPediatrics has higher revenue and earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than OrthoPediatrics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.05	-$39.65M	-$1.68	N/A
Pulse Biosciences	$350K	5,977.77	-$72.78M	-$1.10	N/A

Pulse Biosciences has a net margin of 0.00% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Pulse Biosciences	N/A	-86.67%	-73.61%

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 77.0% of Pulse Biosciences shares are owned by institutional investors. 32.7% of OrthoPediatrics shares are owned by insiders. Comparatively, 74.0% of Pulse Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, OrthoPediatrics and OrthoPediatrics both had 4 articles in the media. OrthoPediatrics' average media sentiment score of 1.06 beat Pulse Biosciences' score of 0.52 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pulse Biosciences	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

OrthoPediatrics beats Pulse Biosciences on 9 of the 15 factors compared between the two stocks.

How does OrthoPediatrics compare to National Vision?

National Vision (NASDAQ:EYE) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

National Vision presently has a consensus target price of $30.08, suggesting a potential upside of 51.02%. OrthoPediatrics has a consensus target price of $24.78, suggesting a potential upside of 31.31%. Given National Vision's higher possible upside, analysts plainly believe National Vision is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

National Vision has higher revenue and earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$1.99B	0.80	$29.60M	$0.57	34.95
OrthoPediatrics	$236.35M	2.05	-$39.65M	-$1.68	N/A

69.1% of OrthoPediatrics shares are held by institutional investors. 2.4% of National Vision shares are held by company insiders. Comparatively, 32.7% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

National Vision has a net margin of 2.31% compared to OrthoPediatrics' net margin of -16.31%. National Vision's return on equity of 6.41% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	2.31%	6.41%	2.81%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

In the previous week, National Vision had 2 more articles in the media than OrthoPediatrics. MarketBeat recorded 6 mentions for National Vision and 4 mentions for OrthoPediatrics. National Vision's average media sentiment score of 1.58 beat OrthoPediatrics' score of 1.06 indicating that National Vision is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	4 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
OrthoPediatrics	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

National Vision has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Summary

National Vision beats OrthoPediatrics on 11 of the 16 factors compared between the two stocks.

Get OrthoPediatrics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KIDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KIDS vs. The Competition

Export

Metric	OrthoPediatrics	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$480.82M	$7.28B	$6.86B	$12.25B
Dividend Yield	N/A	1.33%	2.67%	9.79%
P/E Ratio	-11.23	48.63	27.14	23.64
Price / Sales	2.05	96.85	517.01	89.03
Price / Cash	112.58	25.71	50.54	59.64
Price / Book	1.37	6.73	10.28	6.07
Net Income	-$39.65M	$162.27M	$3.60B	$331.99M
7 Day Performance	-1.82%	-5.05%	-1.27%	-0.63%
1 Month Performance	-3.82%	-5.86%	-0.37%	-2.00%
1 Year Performance	-17.05%	-2.88%	18.30%	13.62%

OrthoPediatrics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KIDS OrthoPediatrics	3.0755 of 5 stars	$18.87 +0.8%	$24.78 +31.3%	-17.1%	$480.82M	$236.35M	N/A	200
AXGN AxoGen	2.6835 of 5 stars	$38.77 -1.8%	$46.50 +19.9%	+198.9%	$2.10B	$225.21M	N/A	450	Upcoming Earnings
BFLY Butterfly Network	1.2533 of 5 stars	$7.76 -4.2%	$5.56 -28.3%	+210.9%	$2.06B	$97.61M	N/A	460	News Coverage Upcoming Earnings
NVCR NovoCure	2.9683 of 5 stars	$15.55 -3.4%	$23.60 +51.8%	+40.7%	$1.86B	$655.35M	N/A	1,605	Trending News Earnings Report Analyst Forecast Analyst Revision Gap Up
PLSE Pulse Biosciences	1.3941 of 5 stars	$25.46 -1.7%	$30.67 +20.5%	+103.3%	$1.79B	$751K	N/A	140	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KIDS) was last updated on 7/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

OrthoPediatrics (KIDS) Competitors

KIDS vs. AXGN, BFLY, NVCR, PLSE, and EYE

How does OrthoPediatrics compare to AxoGen?

Summary

How does OrthoPediatrics compare to Butterfly Network?

Summary

How does OrthoPediatrics compare to NovoCure?

Summary

How does OrthoPediatrics compare to Pulse Biosciences?

Summary

How does OrthoPediatrics compare to National Vision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

OrthoPediatrics (KIDS) Competitors

KIDS vs. AXGN, BFLY, NVCR, PLSE, and EYE

How does OrthoPediatrics compare to AxoGen?

Which has more volatility and risk, KIDS or AXGN?

Does the media refer more to KIDS or AXGN?

Do analysts prefer KIDS or AXGN?

Do institutionals and insiders have more ownership in KIDS or AXGN?

Is KIDS or AXGN more profitable?

Which has preferable earnings & valuation, KIDS or AXGN?

Summary

How does OrthoPediatrics compare to Butterfly Network?

Do analysts recommend BFLY or KIDS?

Which has more volatility and risk, BFLY or KIDS?

Does the media favor BFLY or KIDS?

Which has higher valuation & earnings, BFLY or KIDS?

Do insiders & institutionals have more ownership in BFLY or KIDS?

Is BFLY or KIDS more profitable?

Summary

How does OrthoPediatrics compare to NovoCure?

Is KIDS or NVCR more profitable?

Does the media favor KIDS or NVCR?

Do institutionals and insiders hold more shares of KIDS or NVCR?

Which has stronger earnings & valuation, KIDS or NVCR?

Do analysts rate KIDS or NVCR?

Which has more volatility and risk, KIDS or NVCR?

Summary

How does OrthoPediatrics compare to Pulse Biosciences?

Do analysts rate KIDS or PLSE?

Which has more risk & volatility, KIDS or PLSE?

Which has better valuation & earnings, KIDS or PLSE?

Is KIDS or PLSE more profitable?

Do institutionals & insiders hold more shares of KIDS or PLSE?

Does the media refer more to KIDS or PLSE?

Summary

How does OrthoPediatrics compare to National Vision?

Do analysts prefer EYE or KIDS?

Which has stronger earnings and valuation, EYE or KIDS?

Do insiders and institutionals hold more shares of EYE or KIDS?

Is EYE or KIDS more profitable?

Does the media prefer EYE or KIDS?

Which has more risk & volatility, EYE or KIDS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KIDS vs. The Competition

OrthoPediatrics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools